Please use this identifier to cite or link to this item:
https://covid-19.conacyt.mx/jspui/handle/1000/1193| Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19? | |
| Hong, X Xiong, J Feng, Z Shi, Y | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| Highlights • ECMO has been used as a rescue therapy for severe respiratory failure and ARDS for years and ECMO should also be considered as a rescue therapy for COVID-19 with refractory hypoxemia despite lung-protective ventilation according to WHO. • Although the clinical trials of ECMO for COVID-19 are lacking, its use in COVID-19 might also offer promise based on the previous experience. • In the current situation of pandemic outbreak, many issues of ECMO use deserve our attention. | |
| International Journal of Infectious Diseases | |
| 2020 | |
| Preimpreso | |
| https://coronavirus.1science.com/item/efeb6e11f8f6bd119ace67e2b4591d130bf9d5de | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Appears in Collections: | Artículos científicos |
Upload archives
| File | Size | Format | |
|---|---|---|---|
| 106461.pdf | 1.47 MB | Adobe PDF | View/Open |